Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001801198-25-000021
Filing Date
2025-05-13
Accepted
2025-05-13 07:00:43
Documents
71
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 6-K legn-20250331.htm   iXBRL 6-K 605229
2 EX-99.1 a991earningsreleaseq12025.htm EX-99.1 150520
3 EX-99.4 q125-pipeline51225.htm EX-99.4 2573
4 EX-99.5 exhibit995tariffriskfactor.htm EX-99.5 8901
10 legendlogo.jpg GRAPHIC 6967
11 q125-pipeline51225001.jpg GRAPHIC 122047
  Complete submission text file 0001801198-25-000021.txt   3804785

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT legn-20250331.xsd EX-101.SCH 51322
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT legn-20250331_cal.xml EX-101.CAL 82754
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT legn-20250331_def.xml EX-101.DEF 85036
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT legn-20250331_lab.xml EX-101.LAB 353574
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT legn-20250331_pre.xml EX-101.PRE 239731
73 EXTRACTED XBRL INSTANCE DOCUMENT legn-20250331_htm.xml XML 407578
Mailing Address 2101 COTTONTAIL LANE SOMERSET NJ 08873
Business Address 2101 COTTONTAIL LANE SOMERSET NJ 08873 732-850-5598
Legend Biotech Corp (Filer) CIK: 0001801198 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39307 | Film No.: 25937082
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)